OUR United_Life Sciences_YIJING CAPITAL

OUR United
OUR United develops integrated precision radiotherapy solutions, with three strategic platforms spanning stereotactic radiosurgery, X/γ integrated radiotherapy, and digital oncology. Its iSRS platform supports stereotactic radiosurgery with Gamma Knife-level precision; TaiChiRT integrates X-ray and gamma-ray radiotherapy and has been recognized as a Breakthrough Device by the U.S. FDA; and DOSS is a cloud-based digital oncology platform designed to enable connected diagnostic and treatment services. Through proprietary technologies and a robust intellectual property portfolio, OUR United is advancing more precise, intelligent, and accessible radiotherapy solutions
OUR United
We Look Forward to Hearing from You
Discovering talent, investing in the future, and growing with visionary entrepreneurs

Submit BP

Yijing Capital focuses on innovative companies in frontier technology, life sciences, and related fields. Please complete the basic project information and upload the latest version of your business plan (BP). Our investment team will evaluate the materials and contact projects that align with our investment focus.

All submitted materials will be used solely for investment evaluation. We will strictly protect your business information.

Thank you for your trust in Yijing Capital.
We have received your business plan. After completing an initial evaluation, our investment team will contact projects that align with our investment focus. Due to the volume of submissions, we appreciate your understanding if you do not receive a follow-up. We wish your project every success!

OK